- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
Value score of at least 4 focused on companies with a low market cap.
4 companies
Kontafarma China Holdings
Market Cap: HK$150.9m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.027
7D
-10.0%
1Y
-12.9%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$367.7m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.33
7D
3.1%
1Y
-1.5%
Austar Lifesciences
Market Cap: HK$410.1m
An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.80
7D
2.6%
1Y
11.1%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$186.3m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.11
7D
-6.7%
1Y
-35.5%